CHX Stock Overview
Ciech S.A. manufactures and sells various chemical products in Poland, other European Union countries, Africa, Asia, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 4/6 |
Ciech S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł12.04 |
52 Week High | zł13.30 |
52 Week Low | zł8.66 |
Beta | 0.94 |
11 Month Change | 0% |
3 Month Change | 5.61% |
1 Year Change | 34.60% |
33 Year Change | 84.38% |
5 Year Change | 15.33% |
Change since IPO | -18.37% |
Recent News & Updates
Recent updates
Shareholder Returns
CHX | DE Chemicals | DE Market | |
---|---|---|---|
7D | 0% | -0.9% | 0.8% |
1Y | 34.6% | -0.5% | 8.6% |
Return vs Industry: CHX exceeded the German Chemicals industry which returned -5.4% over the past year.
Return vs Market: CHX exceeded the German Market which returned 4.3% over the past year.
Price Volatility
CHX volatility | |
---|---|
CHX Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 4.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CHX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CHX's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1945 | 3,343 | Kamil Majczak | www.ciechgroup.com |
Ciech S.A. manufactures and sells various chemical products in Poland, other European Union countries, Africa, Asia, and internationally. It operates through Soda, Foam, Silicates, and Packaging segments. The company offers soda ash and baking soda, evaporated salt, agrochemical products, polyurethane foams, lanterns and jars, and sodium and potassium silicates.
Ciech S.A. Fundamentals Summary
CHX fundamental statistics | |
---|---|
Market cap | €641.78m |
Earnings (TTM) | €84.45m |
Revenue (TTM) | €1.29b |
7.6x
P/E Ratio0.5x
P/S RatioIs CHX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CHX income statement (TTM) | |
---|---|
Revenue | zł5.61b |
Cost of Revenue | zł4.55b |
Gross Profit | zł1.06b |
Other Expenses | zł692.32m |
Earnings | zł367.53m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 6.97 |
Gross Margin | 18.90% |
Net Profit Margin | 6.55% |
Debt/Equity Ratio | 77.8% |
How did CHX perform over the long term?
See historical performance and comparison